<DOC>
	<DOCNO>NCT02011971</DOCNO>
	<brief_summary>Pilot study healthy volunteer patient epilepsy assess potential efficacy safety different dosage vinpocetine improve cognition .</brief_summary>
	<brief_title>Cognitive Effects Vinpocetine Healthy Adults Patients With Epilepsy</brief_title>
	<detailed_description>Cognitive problem common patient epilepsy , currently specific treatment available . Vinpocetine chemical obtain leave Lesser Periwinkle . It show improve cerebral metabolism memory animal human . In addition , show enhance long-term potentiation , link memory mechanism . Furthermore , vinpocetine show anticonvulsant effect potent several commonly use antiepileptic drug ( i.e. , carbamazepine , phenytoin , valproate , oxcarbazepine , lamotrigine topiramate ) inhibit sodium calcium channel , control release excitatory neurotransmitter lead brain injury . Thus , vinpocetine might offer unique drug help cognition patient epilepsy . The investigator propose conduct pilot study healthy volunteer patient epilepsy assess potential efficacy safety different dosage vinpocetine improve cognition . Specific Aim 1a : To determine vinpocetine enhances memory cognitive function healthy volunteer . Specific Aim 1b : To determine blood level 3 different acute oral dos vinpocetine healthy volunteer . Specific Aim 2a : To provide safety preliminary efficacy data vinpocetine enhance memory cognitive function patient epilepsy . Specific Aim 2b : To determine blood level acute chronic oral dos vinpocetine patient epilepsy well effect anticonvulsant blood level . Specific Aim 2c : To provide preliminary data vinpocetine reduce seizure frequency duration patient epilepsy .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Vinpocetine</mesh_term>
	<mesh_term>Vinca Alkaloids</mesh_term>
	<criteria>Inclusion Criteria Healthy 1 . Healthy adult 1860 year old 2 . Proficient English 3 . Use appropriate contraception woman childbearing potential . This must include complete abstinence duration study use barrier method plus one contraceptive method ( e.g . hormonal contraception intrauterine device , IUD ) . Inclusion Criteria Epilepsy 1 . Adults ( 1860 year old ) localization relate epilepsy 2 . Patient stable antiepileptic drug therapy last 2 month willing remain therapy duration study . 3 . Proficient English 4 . Patient complain memory problem . 5 . Neurological Disorders Depression Index Epilepsy ( NDDIE ) score &lt; 16 6 . MiniMental Status Exam ( MMSE ) score &lt; 22 7 . No history status epilepticus last year 8 . No prior epilepsy surgery 9 . Stable antiepileptic drug ( AED ) therapy last 2 month willing change 2 month . Vinpocetine stop patient withdrawn study mark change occur seizure adverse event occur . 10 . Use appropriate contraception woman childbearing potential . This must include complete abstinence duration study use barrier method plus one contraceptive method ( e.g . hormonal contraception IUD ) . Exclusion Criteria Healthy : 1 . Major medical disease ( e.g. , epilepsy , diabetes , heart disease , active cancer , depression ) 2 . Subject lifetime history suicide attempt ( include active attempt , interrupt attempt , aborted attempt ) , suicidal ideation past 6 month indicate positive response ( 'Yes ' ) either Question 4 Question 5 Columbia Suicide Severity Rating Scale ( CSSRS ) Screening . 3 . Use centrally active medication 4 . History allergy vinpocetine 5 . Scores onintelligence quotient ( IQ ) &lt; 80 Medical College Georgia ( MCG ) Paragraph score &lt; 2 standard deviation norm . 6 . Pregnancy lactation . Exclusion Criteria Epilepsy 1 . Major medical disease ( e.g. , diabetes , heart disease , active cancer , depression ) 2 . Use centrally active medication 3 . History allergy vinpocetine 4 . Progressive Cerebral Disease ( e.g. , Alzheimer 's disease ) 5 . Aphasia 6 . Taking 3 AEDs 7 . Pregnancy lactation 8 . Subject lifetime history suicide attempt ( include active attempt , interrupt attempt , aborted attempt ) , suicidal ideation past 6 month indicate positive response ( 'Yes ' ) either Question 4 Question 5 CSSRS Screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>epilepsy</keyword>
	<keyword>cognition</keyword>
	<keyword>memory</keyword>
</DOC>